Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2025-12-24 @ 7:21 PM
NCT ID:
NCT01956903
Eligibility Criteria:
Inclusion Criteria:
* Patients with hematologic malignancies who have undergone allogenic stem cell transplantation and who are diagnosed with acute graft-versus-host-disease refractory to first-line treatment.
* Patients must have adequate cardiac function without evidence of uncontrolled hypertension, congestive heart failure or myocardial infarction within 6 months prior to the process.
* Adequate pulmonary function with no evidence of severe obstructive or restrictive pulmonary disease.
* Be able to understand the information and sign the informed consent.
Exclusion Criteria:
* Patients with uncontrolled disease or in progress at the time of treatment.
* Patients with uncontrolled bacterial, viral or fungal infection.
* Patients with inadequate cardiac or pulmonary function.
* Patients who do not have the required donor.
* Women pregnant or at risk of pregnancy by inadequate contraceptive measures.
* Patients who in the opinion of the investigator are not able to participate in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01956903
Study Brief:
Protocol Section:
NCT01956903